Key facts
- Notable investors include Shaanxi Investment Fund Management, Golden Terra Capital, Shenzhen Lihe Science and Technology Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Huaqing Zhimei
- ·The full record, as it builds
Funding rounds
No funding rounds for Huaqing Zhimei are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huaqing Zhimei
Manufacturer of a bio-3D printing and biomanufacturing system designed to enable scalable production of cell-level biomaterials and support in vitro tissue regeneration. The company offers proprietary bio-3D printing, regenerative synthetic biology, and microfluidic manufacturing systems, enabling regenerative medicine, biomaterials, and life science industries to achieve stable, industrial-scale production of advanced human-engineered biomaterials.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Huaqing Zhimei doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huaqing Zhimei shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huaqing Zhimei in its N-PORT filings yet. We sweep new filings monthly.